Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 5 syntheses or guidelines pooled it, 68 citations in OpenAlex.

1. Individual effects ofFrontiers in genetics · 2022
   Pooled it
2. Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
   Pooled it
3. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
   Pooled it
4. Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.Human genomics · 2013
   Pooled it
5. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.Medical oncology (Northwood, London, England) · 2011
   Pooled it
6. Interaction between CYP1A1 gene polymorphism and environment factors on risk of endometrial cancer.Environmental health and preventive medicine · 2024
   Article
7. Is There Any Association between Glutathione S-transferases M1 and Glutathione S-transferases T1 Gene Polymorphisms and Endometrial Cancer Risk? A Meta-analysis.International journal of preventive medicine · 2017
   Review
8. GSTM1 and GSTT1 copy number variation in population-based studies of endometrial cancer risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2011
   Article
9. Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.Carcinogenesis · 2010
   Article
10. Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer.Human cell · 2009
    Article
11. Germline polymorphism of cancer susceptibility genes in gynecologic cancer.Human cell · 2008
    Review
12. Genetic polymorphisms and endometrial cancer risk.Expert review of anticancer therapy · 2008
    Review
13. Estrogen-metabolizing gene polymorphisms and lipid levels in women with different hormonal status.The pharmacogenomics journal · 2005
    Article
14. Association of p53 genomic instability with the glutathione S-transferase null genotype in gastric cancer in the Portuguese population.Molecular pathology : MP · 1999
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as